| Sign In to gain access to subscriptions and/or personal tools. |
Association of Demographic and Treatment Variables in Long-Term Colon Cancer SurvivalDepartment of General Surgery, Carolinas Medical Center, Charlotte, North Carolina
Department of General Surgery, Carolinas Medical Center, Charlotte, North Carolina
Department of General Surgery, Carolinas Medical Center, Charlotte, North Carolina
Department of General Surgery, Carolinas Medical Center, Charlotte, North Carolina, American College of Surgeons Commission on Cancer and the Colorectal Disease Site Team, Chicago, Illinois
Department of General Surgery, Carolinas Medical Center, Charlotte, North Carolina
Department of General Surgery, Carolinas Medical Center, Charlotte, North Carolina
Department of Surgery, Central Arkansas Veterans Healthcare System/University of Arkansas for Medical Sciences, Little Rock, Arkansas
Department of General Surgery, Carolinas Medical Center, Charlotte, North Carolina
Department of General Surgery, Carolinas Medical Center, Charlotte, North Carolina, todd.heniford{at}carolinashealthcare.org
The purpose of this study is to examine demographic and treatment variables because they relate to 5-year survival in colon cancer. The study design is analysis of 174 471 patients with colon and rectosigmoid cancer as reported to the American College of Surgeons National Cancer Data Base. Factors associated with a reduced risk of mortality included female gender (hazard ratio = 0.89; 95% confidence interval, 0.87-0.90), education status (hazard ratio = 0.87; 95% confidence interval, 0.85-0.89), increased number of lymph nodes resected (compared with <8, 8-12: hazard ratio = 0.90; 95% confidence interval, 0.89-0.92; >12: hazard ratio = 0.79; 95% confidence interval, 0.77-0.80), and addition of chemotherapy (hazard ratio = 0.69; 95% CI, 0.68-0.71). African American race (hazard ratio = 1.14; 95% confidence interval, 1.11-1.18) and increasing age correlated with an increased hazard risk (61-75 years: hazard ratio = 1.26; 95% confidence interval, 1.23-1.29;
Key Words: colon cancer demographics survival lymph node adjuvant therapy
This version was published on March
1, 2008 Surgical Innovation, Vol. 15, No. 1,
17-25 (2008) |
|||
76 years: hazard ratio = 2.15; 95% confidence interval, 2.09-2.21, compared with age <60 years). Survival in colon cancer is significantly impacted by patient's age, race, gender, and education status but not by income or area of residence.